发明授权
US08426571B2 Nucleic acids and corresponding proteins entitled 202P5A5 useful in treatment and detection of cancer
失效
核酸和相应的蛋白质，名称为202P5A5，可用于治疗和检测癌症
- 专利标题： Nucleic acids and corresponding proteins entitled 202P5A5 useful in treatment and detection of cancer
- 专利标题（中）： 核酸和相应的蛋白质，名称为202P5A5，可用于治疗和检测癌症
-
申请号： US13021202申请日： 2011-02-04
-
公开(公告)号： US08426571B2公开(公告)日： 2013-04-23
- 发明人: Arthur B. Raitano , Mary Faris , Pia M. Challita-Eid , Aya Jakobovits , Wangmao Ge
- 申请人： Arthur B. Raitano , Mary Faris , Pia M. Challita-Eid , Aya Jakobovits , Wangmao Ge
- 申请人地址： US CA Santa Monica
- 专利权人： Agensys, Inc.
- 当前专利权人： Agensys, Inc.
- 当前专利权人地址： US CA Santa Monica
- 代理机构： Morrison & Foerster LLP
- 主分类号： C07H21/02
- IPC分类号： C07H21/02 ; C12N15/00 ; C12N1/20 ; C12P21/06
摘要：
A novel gene 202P5A5 and its encoded protein, and variants thereof, are described wherein 202P5A5 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 202P5A5 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 202P5A5 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 202P5A5 can be used in active or passive immunization.
公开/授权文献
信息查询
